Neo Ivy Capital Management Makes New $472,000 Investment in HealthEquity, Inc. (NASDAQ:HQY)

Neo Ivy Capital Management bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,770 shares of the company's stock, valued at approximately $472,000.

Other large investors have also recently added to or reduced their stakes in the company. International Assets Investment Management LLC purchased a new stake in shares of HealthEquity during the 2nd quarter valued at $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity in the 3rd quarter worth about $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of HealthEquity in the 2nd quarter valued at about $73,000. GAMMA Investing LLC grew its holdings in shares of HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company's stock worth $77,000 after purchasing an additional 344 shares during the period. Finally, Quarry LP increased its position in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock worth $110,000 after purchasing an additional 1,089 shares in the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares in the company, valued at approximately $6,750,591.64. This represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 18,786 shares of company stock worth $1,722,387 over the last 90 days. Insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

HQY has been the subject of several research reports. JMP Securities boosted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday. The Goldman Sachs Group assumed coverage on HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 target price on the stock. Barrington Research upped their price target on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. Bank of America boosted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. Finally, BTIG Research lifted their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.71.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded down $2.36 during trading on Thursday, reaching $95.00. The stock had a trading volume of 635,332 shares, compared to its average volume of 634,222. The firm's 50 day moving average price is $93.81 and its two-hundred day moving average price is $84.07. HealthEquity, Inc. has a one year low of $62.10 and a one year high of $105.82. The stock has a market cap of $8.30 billion, a PE ratio of 79.17, a P/E/G ratio of 1.57 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.